| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.9M | -14.2% |
| Cost of Revenue | $2.4M | +402.7% |
| R&D Expense | $73.7M | +25.4% |
| SG&A Expense | $22.2M | -12.7% |
| Operating Income | -$84.4M | +5.6% |
| Pre-tax Income | -$78.2M | +1.6% |
| Income Tax | $1.4M | +164.0% |
| Net Income | -$79.6M | -3.0% |
| EPS (Basic) | -$1.28 | +3.0% |
| EPS (Diluted) | -$1.28 | +3.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.4M | -20.8% |
| Short-term Investments | $51.4M | -52.1% |
| Current Assets | $72.1M | -45.6% |
| Total Assets | $91.5M | -41.8% |
| Current Liabilities | $21.1M | +19.5% |
| Total Liabilities | $38.1M | +4.6% |
| Stockholders' Equity | $53.4M | -55.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$63.5M | -10.1% |
| Capital Expenditures | $9K | -96.2% |
| Investing Cash Flow | $58.9M | +621.7% |
| Financing Cash Flow | $594K | -99.0% |
| Free Cash Flow | -$63.5M | -9.7% |